Fenbendazole is an anthelmintic medication primarily used to treat parasitic infections in animals. While there has been some anecdotal information and ongoing research suggesting that Fenbendazole for cancer might have potential anti-cancer properties, its use in cancer treatment in humans is not well-established or approved by regulatory authorities like the U.S. Food and Drug Administration (FDA). Cancer treatment should rely on evidence-based and clinically approved therapies prescribed by oncologists. It is essential to consult with qualified medical professionals for proper guidance and to explore the most appropriate and scientifically validated treatment options based on the specific type and stage of cancer.